Article
New York - With expected advances in immunotherapy, the future is bright for nonsurgical treatment of nonmelanoma skin cancer, said John K. Geisse, M.D., at the American Academy of Dermatology Academy '04 here recently.
Reflecting on the Growth of NPs and PAs in Dermatology
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Bridging Therapeutic Innovation and Dermatology
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Nektar Therapeutics Completes Enrollment for Phase 2b REZOLVE-AD Trial of Rezpegaldesleukin
Study Reveals Immune Checkpoint Inhibitor Treatment and Monitoring Practices Post-Remission